Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $56.17M.
ENTERPRISE VALUE (EV)
$56.17M
Celularity Inc.
Market Cap
$48.34M
Enterprise Value (EV)
$56.17M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Celularity Inc. (CELU) | $48.34M | $56.17M |
| Lite Strategy, Inc. (LITS)vs › | $47.81M | $42.10M |
| Microbot Medical Inc. (MBOT)vs › | $49.44M | $47.17M |
| Clene Inc. (CLNN)vs › | $49.71M | $62.38M |
| Apollomics, Inc. (APLM)vs › | $49.85M | $47.22M |
| INmune Bio, Inc. (INMB)vs › | $50.25M | $33.24M |
| biote Corp. (BTMD)vs › | $51.16M | $168.64M |
| Envoy Medical, Inc. (COCH)vs › | $51.33M | $32.47M |
| DarioHealth Corp. (DRIO)vs › | $45.32M | $71.10M |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.44M | N/A |
Market Cap
$48.34M
Total Debt
$14.00M
Cash
$6.17M
Enterprise Value
$56.17M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
